Miscellaneous News

RSS
Joseph Finn announces inclusion of PRX-08066 therapeutics program in Phase 2 for respiratory indication

Joseph Finn announces inclusion of PRX-08066 therapeutics program in Phase 2 for respiratory indication

Transcept Pharmaceuticals' agreement with Purdue Pharmaceutical Products may lead to staff reduction

Transcept Pharmaceuticals' agreement with Purdue Pharmaceutical Products may lead to staff reduction

Indoor Tanning Association denounces Suffolk Bill banning teens under the age of 18 from using a sun-bed

Indoor Tanning Association denounces Suffolk Bill banning teens under the age of 18 from using a sun-bed

TBI's new Ocular Services Division to replace its Tissue Distribution and Information Center

TBI's new Ocular Services Division to replace its Tissue Distribution and Information Center

New study suggests financial situation of U.S. hospitals improving

New study suggests financial situation of U.S. hospitals improving

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

Minnetronix announces Charles Garcia as President of Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers

Minnetronix announces Charles Garcia as President of Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers

FDA places Geron Corporation's IND for spinal cord injury on clinical hold

FDA places Geron Corporation's IND for spinal cord injury on clinical hold

Dental neglect may indicate wider child neglect and abuse

Dental neglect may indicate wider child neglect and abuse

Amarex joins OmniComm Systems' CRO Preferred Program

Amarex joins OmniComm Systems' CRO Preferred Program

Second BioPharm America partnering event aims to address key industry issues

Second BioPharm America partnering event aims to address key industry issues

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Arcadia Resources to meet institutional investors at Barrington Research Healthcare Conference

Arcadia Resources to meet institutional investors at Barrington Research Healthcare Conference

API Healthcare offers new business analytics solution for enterprise workforce information analysis

API Healthcare offers new business analytics solution for enterprise workforce information analysis

H1N1 vaccine administration coverage from Anthem Blue Cross and Blue Shield in New Hampshire

H1N1 vaccine administration coverage from Anthem Blue Cross and Blue Shield in New Hampshire

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

AMG-SIU to discuss the essentials of audit preparation at the NAMPI conference

AMG-SIU to discuss the essentials of audit preparation at the NAMPI conference

Algos Therapeutics changes name to Algos Preclinical Services

Algos Therapeutics changes name to Algos Preclinical Services

Agito Networks announces 2009 CIO 100 award winner

Agito Networks announces 2009 CIO 100 award winner

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.